Clearfield, Inc. (CLFD) Tops Q4 EPS by 13c ; Offers Guidance

Clearfield, Inc. (NASDAQ: CLFD) reported Q4 EPS of ($0.06), $0.13 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $46.8 million versus the consensus estimate of $41.95 million.

GUIDANCE:

Clearfield, Inc. sees Q1 2025 EPS of ($0.28)-($0.35), versus the consensus of ($0.30). Clearfield, Inc. sees Q1 2025 revenue of $33-38 million, versus the consensus of $38.2 million.

Clearfield, Inc. sees FY2025 revenue of $170-185 million, versus the consensus of $161.9 million.

For earnings history and earnings-related data on Clearfield, Inc. (CLFD) click here.

You May Also Be Interested In

• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18